The Council of Scientific and Industrial Research (CSIR), through its New Millennium Indian Technology Leadership Initiative (NMITLI) program, has approved a project towards development of human monoclonal antibodies (hmAbs) that can neutralize SARS-CoV-2 in patients. This project on generation of neutralizing human monoclonal antibodies as a therapeutic strategy will be implemented by a multi-institutional and multi-disciplinary team.
source https://www.pharmatutor.org/pharma-news/2020/new-project-to-develop-human-monoclonal-antibodies-for-neutralizing-sars-cov-2
No comments:
Post a Comment